Arthur D. Riggs, City of Hope diabetes researcher who pioneered recombinant DNA technology, dies at 82

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Arthur D. Riggs, the diabetes expert who developed the technology that led to the first human synthetic insulin for the treatment of diabetes, died March 23 at age 82 after battling cancer.  A biotechnology pioneer and a longtime leader at City of Hope, Riggs served as director emeritus of Beckman Research Institute of City of Hope...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

The recent ASCO guideline update on palliative care for cancer patients represents a significant milestone in our field’s evolution. This evidence-based guidance emphasizes what I’ve advocated throughout my career—that palliative care must be integrated early and concurrently throughout the cancer journey. This holistic approach to cancer care has been my life’s work and passion. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login